The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.
Orr JG, Currie CJ, Berni E, Goel A, Moriarty KJ, Sinha A, Gordon F, Dethier A, Dillon JF, Clark K, Richardson P, Middleton P, Patel V, Shawcross D, Preedy H, Aspinall RJ, Hudson M.
Orr JG, et al. Among authors: moriarty kj.
Liver Int. 2016 Sep;36(9):1295-303. doi: 10.1111/liv.13111. Epub 2016 Apr 5.
Liver Int. 2016.
PMID: 26950766